Orion Pharma

Orion Pharma

Orion Pharma approves 12% cash dividend

Orion Pharma approves 12% cash dividend

Also, Orion Infusion Limited approved a 10% cash dividend

Orion Pharma: Unaudited 1st quarterly financial statement

Orion Pharma: Unaudited 1st quarterly financial statement

Orion Pharma: Un-audited Third Quarterly (Q3) Financial Statements

Orion Pharma: Un-audited Third Quarterly (Q3) Financial Statements

Orion Pharma’s power subsidiaries seek extension

Orion Pharma’s power subsidiaries seek extension

Agreement of Orion’s two power plants to be expired in 2021

Agreement of Orion’s two power plants to be expired in 2021

Photo: Collected.

Stocks inch up despite low turnover

Orion Pharma in talks for producing Russian Sputnik V vaccine locally

Orion Pharma in talks for producing Russian Sputnik V vaccine locally

Orion Pharma wins ICSB Award for corporate governance

Orion Pharma wins ICSB Award for corporate governance

Orion Pharma wins SAFA award 2019

Orion Pharma wins SAFA award 2019

Representational image. Picture: Collected

Three pharma companies ordered to repay intercompany loans

Orion Pharma: Un-Audited Third Quarterly (Q3) Financial Statements - DSE

Orion Pharma: Un-Audited Third Quarterly (Q3) Financial Statements - DSE

Orion Pharma: Un-Audited Third Quarterly (Q3) Financial Statements - CSE

Orion Pharma: Un-Audited Third Quarterly (Q3) Financial Statements - CSE

Orion Pharma: Un-Audited Third Quarterly (Q3) Financial Statements - BSEC

Orion Pharma: Un-Audited Third Quarterly (Q3) Financial Statements - BSEC